Did You See Kamala Harris' Fourth of July Post? Is the Woman Brain...
On This Independence Day, Re-Watch the Greatest Swimming Relay Race (and Comeback) of...
BREAKING: The One Big Beautiful Bill Is Now Law
ABC News, NYT, Marquette, and CBS News Polled on Mass Deportations. It Will...
White House Accuses This Museum of Using Taxpayer Funds to Undermine America
Could a Future President Deport Melania Trump? One Pundit Thinks So.
America 250 Celebrations to Include UFC Fight at White House
Elon Musk Offers an Update on His Plans to Form a Third Party
Another Wildfire Has Hit California and Newsom's Plan Is to Attack Trump
Yikes! Did You See How Biden Celebrated the 4th of July Holiday Weekend...
The Fact-Checkers Once Again Race to Defend Mamdani
It's No Wonder Randi Weingarten Deleted This '4rth of July' Post
Scott Jennings Offers a Telling Reminder on Democrats' 'Big Tent' Amidst Concerns With...
Trump Marks 4th of July With ‘America First’ Push: Foreign Tourists to Pay...
Adam Schiff's Post About the 4th of July Sure Was Something
Tipsheet

Tuberville Demands Answers From HHS Secretary Over Restriction of Antibody Treatments

AP Photo/Butch Dill

Health and Human Services (HHS) Secretary Xavier Becerra recently took control of the distribution of life-saving monoclonal antibody (mAb) treatments for coronavirus. The department now has the authority to regulate the distribution and usage of the treatment in all 50 states and restrict states that are using what the government determines as more than the “fair share.” 

Advertisement

Senator Tommy Tuberville (R-AL) argues that the rule singles out Republican-led states, and pushed for an explanation on the decision in a letter to Becerra.

“HHS will now mandate providers appeal to their state health departments for mAb orders. State health departments must then look to HHS to tell them exactly how many doses they are permitted to receive that particular week, dependent on a formula that HHS has yet to explain in specific detail. In the days since this change was reported, my office has been inundated with pleas for help from providers whose mAb orders were not fulfilled. This announced change in policy is already affecting lives – patients are being turned away who otherwise could be treated with mAb drugs. It is imperative that HHS explain why these changes come at such a critical time and why states that most need these treatments the most are being targeted,” Tuberville wrote. “It is my understanding that seven states (Alabama, Florida, Texas, Mississippi, Tennessee, Georgia, and Louisiana – notably, majority-Republican states) were told that they would likely have their supply of mAb drugs reduced by the new protocols. While I certainly understand that these states may have lower vaccination and higher hospitalization rates than others, it stands to reason that they would benefit more from a steady and direct supply of mAb treatments to keep hospitalization rates down.”

Advertisement

 He went on to ask about specific metrics that led to the department’s decision, which the rule does not specify.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement